MAPK3 and cancer: Several reports have shown that sE-cad inhibits apoptosis and has an important function in cancer progression via activation of several signaling cascades linked to tumor progression, such as the EGFR and IGF-1R signaling pathways, and consequent activation of ERK1/2 and PI3K signaling [5,7,8,13].